Connexin 36 Mediates Orofacial Pain Hypersensitivity Through GluK2 and TRPA1

Li Qian,Ma Tian-Le,Qiu You-Qi,The First Hospital Affiliated with Shandong First Medical University,Chen Teng,Zhang Wen-Wen,Wang Jing,Mao-Ying Qi-Liang,Mi Wen-Li,Wang Yan-Qing,Chu Yu-Xia
DOI: https://doi.org/10.1007/s12264-020-00594-4
IF: 5.271
2020-01-01
Neuroscience Bulletin
Abstract:Trigeminal neuralgia is a debilitating condition, and the pain easily spreads to other parts of the face. Here, we established a mouse model of partial transection of the infraorbital nerve (pT-ION) and found that the Connexin 36 (Cx36) inhibitor mefloquine caused greater alleviation of pT-ION-induced cold allodynia compared to the reduction of mechanical allodynia. Mefloquine reversed the pT-ION-induced upregulation of Cx36, glutamate receptor ionotropic kainate 2 (GluK2), transient receptor potential ankyrin 1 (TRPA1), and phosphorylated extracellular signal regulated kinase (p-ERK) in the trigeminal ganglion. Cold allodynia but not mechanical allodynia induced by pT-ION or by virus-mediated overexpression of Cx36 in the trigeminal ganglion was reversed by the GluK2 antagonist NS102, and knocking down Cx36 expression in Nav1.8-expressing nociceptors by injecting virus into the orofacial skin area of Nav1.8-Cre mice attenuated cold allodynia but not mechanical allodynia. In conclusion, we show that Cx36 contributes greatly to the development of orofacial pain hypersensitivity through GluK2, TRPA1, and p-ERK signaling.
What problem does this paper attempt to address?